Patients in the study population more often were male, were obese, presented with higher NYHA class, were current or former smokers, had a history of a pulmonary disease and accordingly more frequently used inhaled beta agonists and inhaled and oral steroids, more often had clinical signs of respiratory tract infection, had lower oxygen saturation rates, and lower BNP values. This evidence concerns the gene NPPB and lung disorder.